Keith Gruen

Keith Gruen

Electronic communication in pharma without an opt-in? Yes, it’s possible

The advent of GDPR has launched an industry of, lawyers, experts, consultants, speakers, many of whom warn pharmaceutical companies about the dangers of communicating with customers without an opt-in. As the consultants tend to say: without an opt-in,...
Read More

Blockchain for Pharma – hype or real?

At a recent gathering of the ysura Innovation Circle, pharma executives as well as outside specialists discussed and debated the place of Blockchain in the pharma industry. The overall consensus was that most business models that use Blockchain do not...
Read More

How to design an opt-in campaign for pharma

As GDPR approaches on 25 May 2018, pharmaceutical companies throughout Europe are scrambling to ensure that they can stay in touch with their HCPs via digital means. This is only possible if the HCP gives the pharmaceutical company explicit consent to...
Read More

Blockchain – fad or game-changer? Pharma Execs to discuss topics shaping the industry

This week marks the sixth edition of the annual ysura Innovation Circle. The exclusive invitation-only event brings together forward-thinking pharma executives from 12 global organizations to talk about the future in pharma sales and marketing on 8-9...
Read More

Whitepaper: Digital, Paper or Both? Best practices in consent collection

GDPR 2018 is coming. Are you prepared? In 2018 a new European-Wide General Data Protection Regulation goes into effect. What does it mean for sales & marketing in the pharmaceutical industry? Is your company prepared for the new processes? Are you...
Read More

KOL Finder awarded with Seal of Excellence from European Commission

ysura’s KOL Finder project, which revolutionizes the way pharmaceutical companies identify Key Opinion Leaders, has received the rare Seal of Excellence from the European Commission. This makes the project fundable through the Horizon 2020 program,...
Read More

Discovering the Rising Stars

In a previous blog post, we discussed the important of Key Opinion Leaders (KOLs) in the pharmaceutical industry. KOLs are health care professionals who carry influence at a medical, political or social level and can therefore promote certain treatments...
Read More

ysura’s point solutions fill the missing gaps – and much more!

Pharmaceutical sales and marketing organizations are tired of big-bang products that promise everything, cost a fortune, take ages to implement and never quite work as advertised. Instead, more and more companies are looking for point solutions to cover...
Read More

Make Multi-Channel really count with Visual Activity Planning

Virtually all pharmaceutical companies have embraced the multi-channel approach. Many have provided their sales reps with new technology to facilitate webinars, personalized emails, conference management, digital content and all the other tools of effective...
Read More

Who are the rising stars and why are they important?

Due to various regulations, the pharmaceutical industry cannot sell and market their products using traditional means. Sales and marketing material must stick entirely to facts that have been proven by neutral organizations such as the FDA or independently clinical...
Read More

News & Events

 


Bitte informieren Sie mich